Regarding the anticancer effect in various cancer types and SVCT2 regulation in the neuronal model of VPA, VPA could serve as an SVCT2 inducer, which induces high-dose AA treatment and increases the synergistic anticancer effect of AA. Here, SLC23A2 is linked to cancer.